|(R)-N-(3-氧代-3-((1,2,3,4-四氢萘-1-基)氨基)丙基)-4-三氟甲氧基)苯甲酰胺|CsnPharm

CAS No.: 2029049-79-2

ML390 is a human DHODH inhibitor that induces differentiation in acute myeloid leukemia.

规格	价格	促销价格	库存	数量

400-920-2911

加入购物车大规格询价

产品咨询

400-920-2911

纯度 & 质量文件批次:

生物活性

描述Dihydroorotate dehydrogenase (DHODH) catalyzes the oxidation of dihydroorotate to orotate in de novo pyrimidine synthesis, e.g., uridine 5′-monophosphate. ML390 is a small-molecule probe active in overcoming differentiation arrest in a model of AML (acute myeloid leukemia). Its effect is due to inhibition of DHODH-catalyzed pyrimidine synthesis^[3]. ML390 is very well-tolerated with limited cytotoxicity at high concentration when assayed against cultures of normal human primary bone marrow cells. ML390 triggers myeloid differentiation in murine and human cell line models of acute myeloid leukemia. The stability of probe ML390 in PBS (0.1% DMSO) was measured and the probe is stable as approximately 100% was present after 24 hours of incubation^[4].
作用机制The (R)-amino tetralin group of ML390 is located within the innermost part of the cavity and makes the closest contact^[3].
参考文献

实验方案

技术信息

CAS号

2029049-79-2

储存条件

分子式

C21H21F3N2O3

运输

蓝冰

分子量

406.40

别名

溶解度

DMSO	127.5 mg/mL (313.7 mM)
Water	insoluble

动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

请登录您的专属账户